// App-Quantinova.ai

4997 : Novel anti-PD-L1/IL-15 bifunctional immunotherapeutics potentiates antitumor immunity

Researchers

Presenter

  • Yan Wu

Principal Investigators

  • Zhaojing Zhong

  • Stella Martomo

  • Dan Lu

  • Haifan Zhang

  • Zhanna Polonskaya

  • Xenia Luna

  • Zhikai Zhang

  • Zhun Wang

  • Leo Liu

  • Jeegar Patel

  • James Tonra

  • Henry Li

  • Larry Witte

  • Sam Waksal

  • Zhenping Zhu

Medical Centers

  • Kadmon Corporation, New York, NY

  • Crown Bioscience, Inc., Santa Clara, CA

Locations

  • United States

Companies

  • Kadmon Corporation

  • Crown Bioscience Inc

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Natural Killer cells

  • Programmed cell death protein 1

  • Cluster of differentiation 8A

  • Immunoglobulin G

  • Type 1 T helper

Drug/Treatment

  • IL-15

Outcome

  • N/A

Study Design

  • Adaptive

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved